Escalating and Cumulative-Dose Study of Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of A006

Clinical trial NCT01189396 · COMPLETED

Trial details

NCT number: NCT01189396
Sponsor: Amphastar Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Asthma Bronchospasm Chronic Obstructive Pulmonary Disease (COPD)

Start date: 2010-07-01
Primary completion: 2010-12-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.